We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$510M
Cap. Flow
-$2.26B
Cap. Flow %
-9.9%
Top 10 Hldgs %
40.08%
Holding
187
New
21
Increased
43
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$207M
2
ANSS
Ansys
ANSS
+$201M
3
WWD icon
Woodward
WWD
+$192M
4
SWN
Southwestern Energy Company
SWN
+$168M
5
SQSP
Squarespace, Inc.
SQSP
+$130M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$294M
2
NDAQ icon
Nasdaq
NDAQ
+$256M
3
CRM icon
Salesforce
CRM
+$231M
4
AZN icon
AstraZeneca
AZN
+$188M
5
ARMK icon
Aramark
ARMK
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 31.84%
2 Technology 13.48%
3 Financials 9.84%
4 Communication Services 6.79%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
76
Zymeworks
ZYME
$1.67B
$17.1M 0.07%
1,361,000
-240,000
-15% -$2.61M
TAL icon
77
TAL Education Group
TAL
$6.87B
$16.2M 0.07%
1,365,000
– –
TECX
78
Tectonic Therapeutic
TECX
$606M
$15.8M 0.07%
520,397
+89,387
+21% +$1.63M
PGNY icon
79
Progyny
PGNY
$2.2B
$15.6M 0.07%
931,307
-377,193
-29% -$9.05M
TWST icon
80
Twist Bioscience
TWST
$7.25B
$15.4M 0.07%
340,650
+148,650
+77% +$7.07M
DYN icon
81
Dyne Therapeutics
DYN
$4.9B
$15.4M 0.07%
428,000
+422,000
+7,033% +$16.8M
NUVL
82
DELISTED
Nuvalent
NUVL
$15.3M 0.07%
+150,000
New +$12.4M
AMGN icon
83
Amgen
AMGN
$222B
$15.1M 0.07%
47,000
-185,000
-80% -$60.5M
VYGR icon
84
Voyager Therapeutics
VYGR
$201M
$13.4M 0.06%
2,292,000
– –
FLUT icon
85
Flutter Entertainment
FLUT
$16.4B
$12.6M 0.06%
53,270
-147,530
-73% -$30.6M
BDSX icon
86
Biodesix
BDSX
$248M
$8.25M 0.04%
231,840
+137,931
+147% +$4.74M
LTM
87
LATAM Airlines Group S.A.
LTM
$16.3B
$7.93M 0.03%
+300,377
New +$7.49M
VTYX
88
DELISTED
Ventyx Biosciences
VTYX
$6.91M 0.03%
3,170,000
– –
TMDX icon
89
Transmedics
TMDX
$2.91B
$6.91M 0.03%
44,000
+42,000
+2,100% +$6.47M
BBOT
90
BridgeBio Oncology
BBOT
$747M
$6.27M 0.03%
600,000
– –
ANAB icon
91
AnaptysBio
ANAB
$1.68B
$6.16M 0.03%
+183,876
New +$6.28M
MTAL
92
DELISTED
Metals Acquisition
MTAL
$5.68M 0.02%
410,197
– –
CYTK icon
93
Cytokinetics
CYTK
$10.4B
$5.41M 0.02%
102,400
– –
AMLX icon
94
Amylyx Pharmaceuticals
AMLX
$2.54B
$3.73M 0.02%
1,150,221
– –
IVCP
95
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.31M 0.01%
300,000
– –
PCVX icon
96
Vaxcyte
PCVX
$8.64B
$3.2M 0.01%
28,000
-262,000
-90% -$23.6M
PRME icon
97
Prime Medicine
PRME
$559M
$2.9M 0.01%
750,000
– –
VNET
98
VNET Group
VNET
$2.09B
$2.65M 0.01%
650,000
– –
ALVO icon
99
Alvotech
ALVO
$1.29B
$2.38M 0.01%
+199,675
New +$2.32M
MGX icon
100
Metagenomi Therapeutics
MGX
$46.3M
$2.29M 0.01%
1,057,201
-286,000
-21% -$992K
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Farallon Capital Management held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Woodward worth $198M.

  • Farallon Capital Management's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
  • Farallon Capital Management added most to Walt Disney in Q3 2024, an estimated $207M increase.
  • Farallon Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
  • Farallon Capital Management fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
  • Farallon Capital Management opened 21 new positions and closed 22 in Q3 2024.
  • Farallon Capital Management's portfolio value fell 2.2% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.